A New Vitamin D Deficiency Cut-Off Value in Basrah, Iraq

Main Article Content

Majid Alabbood
, Haider Alrubaye

Keywords

Vitamin D, 25-hydroxyvitamin D, parathyroid hormone, Iraq

Abstract

Background: Vitamin D deficiency is a common health issue worldwide. Clinical observations have shown that most healthy individuals living in Iraq and the Middle East are vitamin D deficient. This study aimed to establish the true cut-off value for vitamin D deficiency (25(OH)D) in Basrah, Iraq, by analyzing the value at which parathyroid hormone (PTH) begins to rise above its reference range. Aim: This study sought to determine the true cut-off value for vitamin D deficiency (25(OH)D) in Basrah, Iraq by analyzing the value at which PTH starts to exceed its reference range. Methods: A cross-sectional study was conducted involving 874 apparently healthy subjects from Basrah, Iraq. Serum calcium, creatinine, vitamin D and PTH levels were measured for each participant. Individuals with impaired renal function and primary hyperparathyroidism were excluded from the study. The association between serum 25(OH)D and PTH was examined using multiple logistic regression analysis. The best cut-off value of serum 25(OH)D to predict elevated PTH was determined using receiver operating characteristic (ROC) analysis. Results: The mean values of 25(OH)D and PTH were 16.9 ± 14.9 ng/ml and 129.1 ± 110.5 pg/ml, respectively. If the universal cut-off values were applied, 25-hydroxyvitamin D deficiency was identified in 599 subjects (68.5%) and was inversely related to PTH. Only 139 subjects (15.9%) had optimal 25(OH)D levels. Secondary hyperparathyroidism was found in 487 subjects (45.7%). Using ROC analysis, a serum 25(OH)D value of 12.5 ng/ml was identified as the best cut-off point to predict secondary hyperparathyroidism in the population (sensitivity: 88.2%, specificity: 53.6%). The number of subjects classified as vitamin D deficient decreased to 461 (52.7%) when the new cut-off value was applied. Conclusions: The cut-off value for vitamin D deficiency needs to be redefined in areas where the disease is unexpectedly prevalent. A single cut-off value cannot be universally applied worldwide due to genetic and environmental variations. The new cut-off value is lower than that used globally. Further studies are required to establish new cut-off values.

Abstract 3 | PDF Downloads 1

References

1. Alourfi Z. Rethinking vitamin D deficiency cut-off point: a study among healthy Syrian adults. EC Endocrinol Metab Res. 2019;4:72–82. doi:10.3177/jnsv.66.389
2. Ling Y, Xu F, Xia X, Dai D, Xiong A, Sun R, et al. Vitamin D supplementation reduces the risk of fall in the vitamin D deficient elderly: an updated meta-analysis. Clin Nutr. 2021;40(11):5531–5537. doi:10.1016/j.clnu.2021.09.031
3. Reid IR, Bolland MJ, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383(9912):146–155. doi:10.1016/S0140-6736(13)61647-5
4. Littlejohns TJ, Henley WE, Lang IA, Annweiler C, Beauchet O, Chaves PH, et al. Vitamin D and the risk of dementia and Alzheimer disease. Neurology. 2014;83(10):920–928. doi:10.1212/WNL.0000000000000755
5. Harrison SR, Li D, Jeffery LE, Raza K, Hewison M. Vitamin D, autoimmune disease and rheumatoid arthritis. Calcif Tissue Int. 2020;106:58–75. doi:10.1007/s00223-019-00577-2
6. Shah J, Gurbani S. Association of Vitamin D Deficiency and Mood Disorders: A Systematic Review. In: Vitamin D Deficiency [Internet]. IntechOpen; 2020. Available from: http://dx.doi.org/10.5772/intechopen.90617
7. AlQuaiz AM, Mujammami M, Kazi A, Hasanato RM, Alodhayani A, Shaik SA, et al. Vitamin D cutoff point in relation to parathyroid hormone: a population based study in Riyadh city, Saudi Arabia. Arch Osteoporos. 2019;14:1–10. doi:10.1007/s11657-019-0565-6
8. Boucher BJ. Vitamin D status and its management for achieving optimal health benefits in the elderly. Expert Rev Endocrinol Metab. 2018;13(6):279–293. doi:10.1080/17446651.2018.1533401
9. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:10.1210/jc.2011-0385
10. Maalouf G, Gannagé-Yared M, Ezzedine J, Larijani B, Badawi S, Rached A, et al. Middle East and North Africa consensus on osteoporosis. J Musculoskelet Neuronal Interact. 2007;7(2):131. PMID:17627082
11. Elrayah EE, Rogers L, Doggui R, Al-Jawaldeh A. Vitamin D insufficiency and deficiency in the Eastern Mediterranean Region (EMR)—misconceptions in public health practice: a scoping review 2019–2020. J Nutr Sci Vitaminol. 2020;66(5):389–395. doi:10.3177/jnsv.66.389
12. Hussein IH, Mansour AA, Nwayyir HA, Almomin AMSA, Alibrahim NTY, Alidrisi HA, et al. Real-Life Data on Total Vitamin D3 (25-Hydroxyvitamin D) Concentrations in Basrah, Iraq. Biomed Pharmacol J. 2021;14(4):2191–2198. doi:10.13005/bpj/2317
13. Al Shaikh AM, Abaalkhail B, Soliman A, Kaddam I, Aseri K, Al Saleh Y, et al. Prevalence of vitamin D deficiency and calcium homeostasis in Saudi children. J Clin Res Pediatr Endocrinol. 2016;8(4):461. doi:10.4274/jcrpe.3301
14. Hussain AN, Alkhenizan AH, El Shaker M, Raef H, Gabr A. Increasing trends and significance of hypovitaminosis D: a population-based study in the Kingdom of Saudi Arabia. Arch Osteoporos. 2014;9:1–5. doi:10.1007/s11657-014-0190-3
15. Choi SW, Kweon SS, Choi JS, Rhee JA, Lee YH, Nam HS, et al. Estimation of the cutoff value of vitamin D: the Dong-gu study. J Physiol Anthropol. 2015;34:15. doi:10.1186/s40101-015-0048-4

Similar Articles

11-20 of 137

You may also start an advanced similarity search for this article.